EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Defining a novel DYRK1A-gp130/IL-6R-pSTAT axis that regulates Th17 differentiation

Matthew Malueg, Keagan G Moo iD, Azlann Arnett iD, Thomas H Edwards iD, Susan L Ruskin, Katharina Lambert iD, Aditi Subramanyam iD, Matthew J Dufort iD, Vivian H Gersuk iD, Rebecca Partridge iD, Jane H Buckner iD, Bernard Khor iD

ImmunoHorizons · 2025

DOI: 10.1093/immhor/vlae005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoHorizons, 2025. Verfasst von Matthew Malueg und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, United States. Hauptthemen laut MEDLINE: Th17 Cells, Protein-Tyrosine Kinases, Cell Differentiation, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, Murdock Charitable Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulated differentiation of naïve CD4+ T cells into T helper 17 (Th17) cells is likely a key factor predisposing to many autoimmune diseases. Therefore, better understanding how Th17 differentiation is regulated is essential to identify novel therapeutic targets and strategies to identify individuals at high risk of developing autoimmunity. Here, we extend our prior work using chemical inhibitors to provide mechanistic insight into a novel regulator of Th17 differentiation, the kinase dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A). We generated a conditional knockout mouse model to validate DYRK1A as a regulator of Th17 differentiation that acts in a dose-dependent fashion at least in part by modulating interleukin (IL)-6 signaling through multiple mechanisms. We identified a new role for DYRK1A in regulating surface expression of IL-6 receptor subunits in naïve CD4+ T cells, consistent with DYRK1A’s impact on Th17 differentiation. Physiologic relevance is supported by findings in people with Down syndrome, in which increased expression of DYRK1A, encoded on chromosome 21, is linked to increased IL-6 responsiveness. Our findings highlight DYRK1A as a druggable target of broad therapeutic and prognostic interest in autoimmunity and immune function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Th17 CellsProtein-Tyrosine KinasesCell DifferentiationProtein Serine-Threonine KinasesReceptors, Interleukin-6STAT3 Transcription FactorDyrk KinasesAnimalsMiceMice, KnockoutSignal TransductionInterleukin-6HumansMice, Inbred C57BLCells, CulturedDown Syndrome

Stichwörter der Autor:innen

DYRK1AIL-6 signalingTh17 differentiationgp130

Substanzen

Dyrk KinasesProtein-Tyrosine KinasesProtein Serine-Threonine KinasesInterleukin-6Receptors, Interleukin-6STAT3 Transcription Factor

Autor:innen und Institutionen

  • Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, United States.
  • Center for Systems Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, United States.
  • Department of Pediatrics, Virginia Mason Medical Center, Issaquah, WA, United States.

ORCID-Profile: Keagan G Moo, Azlann Arnett, Thomas H Edwards, Katharina Lambert, Aditi Subramanyam, Matthew J Dufort, Vivian H Gersuk, Rebecca Partridge, Jane H Buckner, Bernard Khor

Förderung

  • NIAID NIH HHS
  • NIDDK NIH HHS
  • Murdock Charitable Trust
  • NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health

Zitieren

APA

Malueg, M., Moo, K. G., Arnett, A., Edwards, T. H., Ruskin, S. L., Lambert, K., Subramanyam, A., Dufort, M. J., Gersuk, V. H., Partridge, R., Buckner, J. H., & Khor, B. (2025). Defining a novel DYRK1A-gp130/IL-6R-pSTAT axis that regulates Th17 differentiation. ImmunoHorizons. https://doi.org/10.1093/immhor/vlae005

Vancouver

Malueg M, Moo KG, Arnett A, Edwards TH, Ruskin SL, Lambert K, et al. Defining a novel DYRK1A-gp130/IL-6R-pSTAT axis that regulates Th17 differentiation. ImmunoHorizons. 2025. doi:10.1093/immhor/vlae005

BibTeX
@article{Malueg2025,
  author = {Malueg, Matthew and Moo, Keagan G and Arnett, Azlann and Edwards, Thomas H and Ruskin, Susan L and Lambert, Katharina and Subramanyam, Aditi and Dufort, Matthew J and Gersuk, Vivian H and Partridge, Rebecca and Buckner, Jane H and Khor, Bernard},
  title = {Defining a novel DYRK1A-gp130/IL-6R-pSTAT axis that regulates Th17 differentiation},
  journal = {ImmunoHorizons},
  year = {2025},
  doi = {10.1093/immhor/vlae005}
}
Kostenlos starten →